Michael Pernula, M.D.
NPI 1598064909 · Ophthalmology Physician · Las Vegas, NV
Enrolled with Medicare as Practitioner - Ophthalmology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1598064909
- Entity type
- Individual
- Primary specialty
- Ophthalmology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- 15879 (NV)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Student, Health Care
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
15 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
669 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Measurement of Corneal Curvature and Depth of Eye92136 | 150 | $23 |
| Imaging of Retina92134 | 75 | $38 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 69 | $122 |
| Removal of Cataract With Insertion of Prosthetic Lens66984 | 68 | $505 |
| Established Patient Complete Exam of Visual System92014 | 61 | $122 |
| Ct Scan of Cornea92025 | 59 | $36 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 13 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Latanoprost | 396 | 136 |
| Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol | 141 | 45 |
| Timolol Maleate | 118 | 48 |
| Cyclosporinebrand: Restasis | 78 | 34 |
| Prednisolone Acetate | 73 | 44 |
| Bimatoprostbrand: Lumigan | 66 | 21 |
| Erythromycin Basebrand: Erythromycin | 40 | 23 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$340 across 6 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2011-03-24
- Last updated
- 2015-08-12
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.